Penumbra Inc (PEN)
212.35
+2.95
(+1.41%)
USD |
NYSE |
May 10, 16:00
212.35
0.00 (0.00%)
After-Hours: 20:00
Penumbra Revenue (Quarterly): 278.66M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 278.66M |
| December 31, 2023 | 284.68M |
| September 30, 2023 | 270.95M |
| June 30, 2023 | 261.50M |
| March 31, 2023 | 241.40M |
| December 31, 2022 | 221.22M |
| September 30, 2022 | 213.68M |
| June 30, 2022 | 208.34M |
| March 31, 2022 | 203.90M |
| December 31, 2021 | 204.01M |
| September 30, 2021 | 190.12M |
| June 30, 2021 | 184.26M |
| March 31, 2021 | 169.20M |
| December 31, 2020 | 166.90M |
| September 30, 2020 | 151.08M |
| June 30, 2020 | 105.11M |
| March 31, 2020 | 137.33M |
| December 31, 2019 | 145.26M |
| September 30, 2019 | 139.50M |
| June 30, 2019 | 134.20M |
| Date | Value |
|---|---|
| March 31, 2019 | 128.44M |
| December 31, 2018 | 120.79M |
| September 30, 2018 | 111.81M |
| June 30, 2018 | 109.64M |
| March 31, 2018 | 102.70M |
| December 31, 2017 | 96.05M |
| September 30, 2017 | 83.91M |
| June 30, 2017 | 80.59M |
| March 31, 2017 | 73.21M |
| December 31, 2016 | 73.10M |
| September 30, 2016 | 67.19M |
| June 30, 2016 | 65.11M |
| March 31, 2016 | 57.92M |
| December 31, 2015 | 54.42M |
| September 30, 2015 | 50.42M |
| June 30, 2015 | 42.31M |
| March 31, 2015 | 38.95M |
| December 31, 2014 | 35.40M |
| September 30, 2014 | 32.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
105.11M
Minimum
Jun 2020
284.68M
Maximum
Dec 2023
195.56M
Average
197.01M
Median
Revenue (Quarterly) Benchmarks
| Stryker Corp | 5.243B |
| Boston Scientific Corp | 3.856B |
| Insulet Corp | 509.80M |
| ResMed Inc | 1.197B |
| Shockwave Medical Inc | 218.80M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.00M |
| Total Expenses (Quarterly) | 266.55M |
| EPS Diluted (Quarterly) | 0.28 |
| Enterprise Value | 7.804B |
| Gross Profit Margin (Quarterly) | 65.00% |
| Profit Margin (Quarterly) | 3.95% |
| Earnings Yield | 1.12% |
| Operating Earnings Yield | 1.15% |
| Normalized Earnings Yield | 1.268 |